Small-molecule RNA therapeutics to target prostate cancer. Read more about Small-molecule RNA therapeutics to target prostate cancer.
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping. Read more about Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. Read more about Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.
Integrating priorities at the intersection of cancer and neuroscience. Read more about Integrating priorities at the intersection of cancer and neuroscience.
Glioblastoma induces the recruitment and differentiation of dendritic-like "hybrid" neutrophils from skull bone marrow. Read more about Glioblastoma induces the recruitment and differentiation of dendritic-like "hybrid" neutrophils from skull bone marrow.
The temporal progression of lung immune remodeling during breast cancer metastasis. Read more about The temporal progression of lung immune remodeling during breast cancer metastasis.
Career trajectories of MD-PhD physician scientists: The loss of women investigators. Read more about Career trajectories of MD-PhD physician scientists: The loss of women investigators.
A road map for the treatment of pediatric diffuse midline glioma. Read more about A road map for the treatment of pediatric diffuse midline glioma.
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Read more about Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression. Read more about Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.
